Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies
Safety and efficacy of MACI in Patients with Chondral or Osteochondral Knee Defects (PEAK)
Full IRB Study Title:
A prospective, open-label, randomized, concurrent active-controlled, longitudinal, multicenter, phase 3 clinical study of the safety and efficacy of MACI in patients aged 10 to 17 years with symptomatic chondral or osteochondral defects of the knee due to osteochondritis dissecans or acute trauma (PEAK Clinical Trial)
IRB Study ID: 1694961
View complete study information here.
Study Sponsor:
Vericel Corporation
We are currently recruiting
If you are interested in this study or have questions about your child's eligibility, please contact:
Melanie Morscher, Study Coordinator, 330-543-8935
Lead Investigator
John Polousky, MD
Division Director, Orthopedic Sports Medicine
Orthopedics
